已收盘 09-06 16:00:00 美东时间
-0.002
-0.22%
MiNK Therapeutics (NASDAQ:INKT) filed a prospectus related to the offer and sale of 4,640,000 shares of common stock by the selling stockholder. This prospectus is not an offer to sell. Filing More on...
08-14 04:45
MiNK Therapeutics (NASDAQ:INKT) said it has regained compliance with the Nasdaq Capital Market’s market value of listed securities requirement. Press Release More on MiNK Therapeutics MiNK Therapeutic...
07-31 19:58
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
05-14 22:50
MiNK Therapeutics press release (NASDAQ:INKT): Q1 Loss per share of $0.11. The company ended the quarter with a cash balance of $5.8 million. More on MiNK Therapeutics MiNK Therapeutics, Inc. (INKT) Q...
05-14 22:25
MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.
05-14 01:48
Gainers: Auddia (AUUD) +231%. Etao International Co Ltd. (ETAO) +143%. Longeveron (LGVN) +56%. Adlai Nortye Ltd. (ANL) +53%. U Power Ltd (UCAR) +33%. MSP Recovery (LIFW) +29%. Techprecision Corp (TPCS...
04-09 00:24
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
03-21 18:15
MiNK Therapeutics (NASDAQ:INKT) is set to give its latest quarterly earnings re...
03-21 00:01
Gainers Sensei Biotherapeutics (NASDAQ:SNSE) shares moved upwards by 13.0% to ...
2023-11-04 05:31
Over the past 3 months, 4 analysts have published their opinion on MiNK Therape...
2023-05-12 21:01